Melanie B. Fukui

Melanie B. Fukui

Auto-generated profile, based on publicly available information

Melanie B. Fukui

Intent Medical Group, Endeavor Health Advanced Neurosciences Institute, Northwest Community Hospital, Arlington Heights, Illinois, USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 June 2020 in World Neurosurgery
Verified
Journal Article
Closed access
WSWilliam Smithee
William Smithee
SCSrikant Chakravarthi
Srikant Chakravarthi
AEAustin Epping
Austin Epping
MKMikaeel Kassam
Mikaeel Kassam
AMAlejandro Monroy-Sosa
Alejandro Monroy-Sosa
AKAmin B. Kassam
Amin B. Kassam

1 December 2016 in Interdisciplinary Neurosurgery
Verified
Journal Article
Open access
SCSrikant S. Chakravarthi
Srikant S. Chakravarthi
AZAnthony Zbacnik
Anthony Zbacnik
JJJonathan Jennings
Jonathan Jennings
MFMelanie B. Fukui
Melanie B. Fukui
NKNathaniel Kojis
Nathaniel Kojis
AKAmin B. Kassam
Amin B. Kassam
BackgroundSurgical approaches to the temporal region for resection of tumors is challenging due to the anatomic complexity and, in particular, understanding of the critical subcortical white matter. Knowledge of the location of white matter fiber tracts and delicate vessels is essential in preventing complications. As a result, accurate navigation, planning and trajectory are necessary in designing a safe corridor for resection.Case descriptionWe describe here a 49-year-old male with a history of right mesial temporal lobe mass since 2012, with concomitant intractable seizures. MRI showed heterogeneous internal enhancement and multiple internal calcifications, resulting in local mass effect with uncal herniation. DTI showed lateral deviation of the Inferior Longitudinal Fasciculus (ILF) and focally diminished anisotropy of the uncinate. The findings were consistent with a WHO grade I pilocytic astrocytoma. BrightMatter Plan software (Synaptive Medical, Toronto, Canada) was then used to plan a trajectory for insertion of a port system (NICO BrainPath, Indianapolis, IN). Complete resection of the tumor, along with partial temporal lobectomy and amygdalohippocampectomy was performed to treat the seizure focus.ConclusionsTo our knowledge, this is the first reported case of a temporal lobectomy and amygdalohippocampectomy using a port technique, in particular, one that demonstrates recovery of the critical (ILF and uncinate fasciculus) subcortical white matter tracts. The combination of real-time, rapid, geometrically accurate 3D-planning of white matter tracts is imperative, especially in conjunction with minimally invasive approaches, thereby offering a new, safer perspective into the approach of temporal lobe lesions

1 February 2016 in Journal of Neurological Surgery Part B: Skull Base
Verified
Journal Article
Closed access
AKAmin Kassam
Amin Kassam
MCMartin J. Corsten
Martin J. Corsten
GCGuillaume Curaudeau
Guillaume Curaudeau
MFMelanie B. Fukui
Melanie B. Fukui
RRRichard Rovin
Richard Rovin
Introduction: Since its introduction in Neurosurgery 50 years ago, the operating microscope has proved indispensable. Over the last several years there has been a significant evolution in optical imaging, robotics and image guidance; recently, an FDA listed robotic optics positioning system has been released for clinical use. At high optical zoom (2X) and a 25 cm working distance, the image guided robotics platform can achieve a field of view of 2.5 cm, similar to the state of the art operating microscope; however, its depth of field is 14 mm, 3X that of the operating microscope thus creating a significantly larger immersive surgical environment. This suggests that the robotic optical platform may have an application in cerebrovascular surgery. To understand the feasibility of introducing this platform to vascular Neurosurgery, this correlative cadaveric and clinical study was undertaken. Methods: To demonstrate the effective volume of view (VoV) with the operating microscope and the robotic optical platform, a cadaveric dissection simulating craniotomy for anterior circulation aneurysm was performed. Clinical feasibility of the use of the robotic optical platform was demonstrated during aneurysm surgery. Results: Videos of the relevant cadaveric anatomy will be presented, defining the anatomic boundaries of the VoV seen with each modality. Operative videos that demonstrate the clinical value of the increased immersive surgical environment afforded by the robotic optical system will also be presented. Between April and July of 2015, four patients with anterior circulation aneurysms were operated on using the image guided robotics platform. There were 3 MCA aneurysms (one acutely ruptured MCA aneurysm, one ruptured and partially coiled and one unruptured), and an unruptured paraophthalmic/carotid cave aneurysm. All surgeries were completed using the robotic optics platform without the need to revert to the conventional microscope. Conclusions: With this first clinical use of the image guided robotic optics platform, the following advantages were noted: • the larger immersive volume of surgical anatomy in focus mitigated the absence of stereoscopic vision and any theoretical loss of 3D. • the larger volume of view permitted more of the osseous framework and neurovascular structures to be seen simultaneously, obviating the need for frequent refocusing. This was especially valuable when temporary clipping in the cases of MCA aneurysm as the VoV extended from proximal ICA to distal M2 branches. • two surgeons using four hands can operate comfortably. • the use of preset positions permits multiple relevant optical trajectories to be viewed rapidly and in sequence which is particularly beneficial for temporary clip placement and assessing multiple angles for clip and blade placement. • hands free positioning allows for uninterrupted work flow. • the robotic optics platform has a smaller footprint in the operating room. • there is a significant ergonomic benefit for the surgeon and learners as all have the same high definition view.

5 July 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DRDaniel Raymond
Daniel Raymond
MFMelanie Fukui
Melanie Fukui
SZSamuel Zwernik
Samuel Zwernik
AKAmin Kassam
Amin Kassam
RRRichard Rovin
Richard Rovin
PAParvez Akhtar
Parvez Akhtar
With current imaging, discriminating tumor progression from treatment effect following immunotherapy or oncolytic virotherapy of glioblastoma (GBM) is challenging. A blood based diagnostic biomarker would therefore be helpful. Axl is a receptor tyrosine kinase that is highly expressed by many cancers including GBM. Axl expression is regulated through enzymatic cleavage of its extracellular domain. The resulting fragment can be detected in serum as soluble Axl (sAxl). sAxl levels can distinguish patients with melanoma, hepatocellular carcinoma, and pancreatic ductal adenocarcinoma from healthy controls. This is a pilot study to determine if sAxl is a candidate biomarker for GBM. The sAxl levels in the serum of 40 healthy volunteers and 20 GBM patients were determined using an enzyme-linked immunosorbent assay (ELISA). Pre- and post- operative sAxl levels were obtained. Volumetric MRI evaluation provided GBM tumor volume metrics. There was no significant difference in the sAxl levels of the volunteers (30.16±1.88 ng/ml) and GBM patients (30.74±1.96 ng/ml) p = 0.27. The postoperative sAxl levels were significantly higher than preoperative levels (32.32±2.26 ng/ml vs 30.74±1.96 ng/ml, p = 0.03). We found no correlation between tumor volume and sAxl levels. Axl expression was low or absent in 6 of 11 (55%) patient derived GBM cell lines. Given the wide range of Axl expression by GBM tumors, sAxl may not be a reliable indicator of GBM. However, given the small sample size in this study, a larger study may be considered.

1 February 2016 in Journal of Neurological Surgery Part B: Skull Base
Verified
Journal Article
Closed access
AKAmin Kassam
Amin Kassam
MFMelanie B. Fukui
Melanie B. Fukui
MCMartin J. Corsten
Martin J. Corsten
RRRichard Rovin
Richard Rovin
JJJohn Jennings
John Jennings
Introduction: There has been increasing interest in and clinical utilization of diffusion tensor imaging (DTI) in Neurosurgery to define white matter tracts and cranial nerves to reduce surgical morbidity. Barriers to the use of DTI in skull base surgery include: 1. geometric inaccuracy with “co-registration” of DTI onto anatomic T1 imaging because of errors in warp correction, 2. inability to use multimodality imaging, 3. lack of 3D rendering that can be manipulated in realtime for surgical trajectory planning, and 4. lengthy processing times. Methods: We report our experience with 50 cases of varied skull base procedures with a recently FDA approved 3D DTI planning system Bright Matter Plan (Synaptive Medical, Toronto, Canada). Tractography data are generated by first performing brain extraction (via template initialization and level set evolution) and skin surface detection (via image statistics). Next the raw diffusion dataset is then corrected for motion and eddy current artifacts. Then this diffusion data are co-registered to an anatomical target (e.g., T1 or T2 contrast volume) using a mutual information metric to find a rigid co-registration matrix. Now the raw diffusion data are used to estimate diffusion tensors (via a dual basis solver) in the anatomical space. Noise in the tensor estimate outside the cranium is attenuated using the surface mask, while the brain mask is used to define a tractography region. Whole brain seeding is then used to generate tracts using a deterministic 4th order Runge-Kutta interpolator. Finally, a cleanup pass is performed to remove noise in the tract data as well as perform geometric simplification of the tract objects. Results: In all cases we were able to obtain accurate 3D geometric fits with multimodality rendering. Processing times of 15min from image acquisition in a automated process improved the ergonomics and minimized the resources needed for processing. The rendering platform accurately merged multiple imaging modalities simultaneously and was transferred to the navigation and robotic optical positioning systems. As a representative example the case of a large olfactory groove meningioma is shown. The perimeter location of the bilateral inferior frontal occipital fibers and the superior longitudinal fasciculus was helpful in selecting an endonasal corridor for this lesion as opposed to a transcranial route. Conclusions: As skull base surgery evolves and recognizes neurocognitive morbidity, the identification of critical fibers that subserve these eloquent processes need to be considered during preoperative planning. BrightMatter Plan addresses the aforementioned barriers: • The ability to plan in multiple orthogonal axes simultaneously and simulate the procedure taking into account the critical position of cranial nerves and fiber tracts was found most useful in large anterior and posterolateral skull base pathologies. • The emergence of an integrated DTI planning system that is quick (15 minute processing time), geometrically accurate, and includes real time 3D rendering that can be fused with multiple imaging modalities represents a valuable surgical tool. • Increasing experience will be needed to correlate postoperative tract preservation with outcome to understand the optimal corridors for skull base surgery based on previously “invisible” anatomy.